Medications That Cause Weight Gain: 8 Classes Explained

Learn which medications that cause weight gain are most common, why effects vary, and how to talk with your clinician before changing any prescription.

· 15 min read

Medications That Cause Weight Gain: 8 Classes Explained

Your clothes feel tighter, and the scale has crept upward since you started a new prescription. The medication seems to be helping, but now you're wondering whether it's responsible for the change, whether you're retaining fluid, and whether you should stop taking it.

Don't stop or reduce a prescribed medicine on your own. Weight changes can reflect increased appetite, fluid retention, changes in activity, improved control of an illness, or several factors together. The timing matters, but a change that follows a prescription doesn't automatically prove the medicine caused it.

The most useful first step is to record the medication's name, dose, start date, and any recent dose changes alongside your weight. Add brief notes about hunger, swelling, sleep, meals, and movement so your prescriber has more than an isolated scale reading to assess.

Start with a pattern, not a verdict. A dated record can support a treatment decision. A drug's appearance on a weight-gain list can't tell you what's happening in your body.

The medications that cause weight gain span very different treatments, from psychiatric medicines to diabetes drugs and hormonal therapies. Their benefits may be essential, and weight effects vary between medicines and individuals. A practical monitoring plan helps you protect those benefits while identifying side effects that deserve attention.

Table of Contents

1. Second-Generation (Atypical) Antipsychotics

Olanzapine, clozapine, quetiapine, and risperidone can affect appetite, fullness, and metabolic health. They're prescribed for conditions including schizophrenia and bipolar disorder, and some are used alongside antidepressants. Their effects on serotonin, dopamine, and other receptors can change hunger signals, while sedation may make regular movement harder.

The differences between medicines can be substantial. In the one-year CAFÉ trial involving people with schizophrenia who had previous or minimal treatment exposure, average weight increased by 11.0 kg with olanzapine and 6.4 kg with risperidone, according to the review of atypical antipsychotic weight gain. These trial averages aren't forecasts for an individual, but they show why monitoring belongs in the treatment plan.

Track hunger as well as weight

Say someone taking olanzapine begins feeling hungry after dinner and sleeping through their usual morning walk. Logging those changes alongside weight gives the psychiatrist concrete concerns to address without assuming the person has stopped trying.

  • Record appetite changes. Note persistent hunger, evening snacking, and whether meals still feel satisfying.
  • Include metabolic monitoring. Keep clinician-requested glucose, HbA1c, and lipid results with medication dates.
  • Discuss the treatment trade-off. Ask whether monitoring, a different agent, or adjunctive treatment could help without destabilizing psychiatric symptoms.

Aripiprazole may have a lower weight-gain risk than some alternatives, but switching isn't automatically the safest choice. Treatment response and relapse risk matter. If you're also navigating a weight-loss plateau, review the medication timeline before responding with increasingly restrictive eating.

2. Systemic Corticosteroids

A person taking prednisone for polymyalgia rheumatica may notice both stronger hunger and tighter shoes. Those observations point toward different contributors: increased food intake and fluid retention. Treating every increase as body fat can lead to unnecessary restriction while missing a symptom the prescriber should assess.

Systemic corticosteroids include prednisone, prednisolone, methylprednisolone, and dexamethasone. They reduce inflammation but can also increase appetite, affect glucose regulation, and cause the body to retain salt and water. Longer exposure can change fat distribution, making the face or abdomen look different even when daily weight changes seem unremarkable.

Separate swelling from appetite changes

Use consistent weighing conditions, such as the same scale after waking and using the bathroom. Alongside the measurement, record swollen ankles, tighter rings, unusually salty meals, hunger, and any prescribed glucose readings.

Understanding why sodium and carbohydrates can cause sudden water gain can prevent an abrupt increase from being mistaken for fat gain. It doesn't establish that a change is harmless, especially when swelling or breathing symptoms appear.

Follow the prescribed dosing and taper schedule exactly. If sleep disruption or evening hunger becomes difficult, ask the pharmacist or prescriber whether timing can be adjusted rather than moving doses yourself. Regular meals with protein and fiber may help manage hunger, but aggressive dieting won't resolve medication-related fluid retention.

A short steroid course and ongoing steroid treatment require different conversations. Bring your actual dosing history, including repeated courses, rather than describing your exposure as taking steroids in general terms.

3. Certain Antidepressants (Mirtazapine, Tricyclics, and Paroxetine)

Antidepressants aren't interchangeable regarding weight. Mirtazapine and tricyclic medicines such as amitriptyline can increase appetite through effects that include histamine-receptor blockade. Paroxetine can also be associated with weight gain, but an individual's response may differ from the average.

The scale can change for reasons beyond a direct drug effect. Someone who barely ate during depression may resume regular meals as treatment works, while another person may develop new cravings or feel too sleepy for their usual activities. Those patterns call for different solutions.

A Cleveland Clinic explanation of antidepressant-associated weight gain summarizes a study finding average gain of about 3 pounds over two years, while emphasizing differences among medications and patients. That's a reason to monitor your own trajectory, not to assume every antidepressant will produce substantial gain.

Make the evening pattern visible

For someone taking mirtazapine at bedtime, the useful question may be whether late-night eating started after treatment or was already present.

  • Log meal timing. Record dinner, later snacks, and whether you felt physically hungry.
  • Note sleep and energy. Better sleep may support activity, while next-day sedation may interfere with it.
  • Bring the benefit into the discussion. Tell your prescriber what improved as well as what became difficult.
A medication that improves depression and sleep may still need a weight-management plan. Benefit and side effects can both be real.

Don't assume switching to another SSRI guarantees weight neutrality. Ask about the overall fit, including prior response, withdrawal symptoms, sleep, and the likely effect of a supervised change.

4. Insulin and Sulfonylureas

Improved glucose control can itself change body weight. When high blood glucose causes glucose to leave through urine, the body loses usable energy. Insulin treatment reduces that loss and helps the body use and store nutrients.

Sulfonylureas, including glipizide, glimepiride, and glyburide, stimulate insulin release. Both insulin and sulfonylureas can cause hypoglycemia, and repeated eating to treat or prevent lows can contribute to weight gain. That makes glucose readings essential context, not an optional addition to the weight log.

A systematic review of medications associated with weight change reported average gains of approximately 2.1 kg with glimepiride and 2.2 kg with glipizide across included trials. Those averages don't identify the cause of a particular person's gain, especially when glucose control, food intake, and other medicines change together.

Link lows, meals, and doses

Consider someone who begins eating a large bedtime snack because they're afraid of overnight lows. The clinical question isn't how to remove the snack. The care team needs to review whether the medication plan is producing or risking hypoglycemia.

  • Record the context. Put glucose readings, meal timing, medication doses, and symptoms on the same timeline.
  • Treat lows safely. Keep fast-acting glucose available and follow your diabetes team's treatment instructions.
  • Ask about options. Discuss whether another treatment fits your glucose needs, medical history, access, and weight priorities.

This video provides additional context for the diabetes-treatment discussion.

Never skip insulin to control weight. Don't reduce food needed to treat a low in pursuit of a calorie target. Recurrent lows need a medication review, not greater willpower.

5. Thiazolidinediones (Pioglitazone and Rosiglitazone)

With pioglitazone or rosiglitazone, the most important distinction is often fluid retention versus gradual tissue gain. These diabetes medicines improve insulin sensitivity through PPAR-gamma receptors, but they can also increase fat storage and cause fluid retention. A rising scale reading therefore needs more context than a food diary alone can provide.

For example, someone taking pioglitazone may report better glucose readings alongside new ankle swelling. The improved glucose doesn't cancel out the swelling, and the swelling shouldn't be dismissed as evidence of overeating. The prescriber needs to assess both treatment benefit and possible adverse effects.

Make fluid symptoms part of the record

If your clinician recommends frequent weights, use consistent conditions and record symptoms beside the measurements. Guidance on whether to weigh yourself every day can help you choose a routine that supports observation without encouraging reactions to every fluctuation.

Useful entries include:

  • Swelling location. Note whether your feet, ankles, legs, or abdomen look or feel different.
  • Breathing and stamina. Record new breathlessness, reduced exercise tolerance, or unusual fatigue.
  • Medication timing. Include the start date, dose changes, and other recently added medicines.
Safety priority: New swelling with rapid weight gain deserves prompt medical advice. Severe breathlessness or chest discomfort requires urgent assessment.

Don't try to correct possible fluid retention with dehydration, nonprescribed diuretics, or severe food restriction. Those approaches can create additional problems without addressing the cause.

Ask the prescriber how your heart-health history and other diabetes treatments affect the decision to continue therapy. The right plan may involve closer monitoring or a treatment change, but that decision belongs with the clinician who knows your medical history.

6. Anticonvulsants with Weight-Gain Potential (Valproate, Gabapentin, and Pregabalin)

A person taking pregabalin for neuropathic pain may become less active because of drowsiness, notice increased hunger, or develop swollen ankles. Each observation suggests a different contribution to weight change. Recording only calories would miss much of that picture.

Valproate, gabapentin, and pregabalin have weight-gain potential, although they don't have identical effects or uses. Valproate can affect appetite and metabolic regulation; gabapentin and pregabalin may contribute through appetite changes, sedation, and peripheral edema.

The Mayo Clinic publication record for a systematic review of drug-related weight change reports an average gain of approximately 2.2 kg with gabapentin across included trials. That finding supports monitoring, but it doesn't tell you whether a particular increase is fluid, fat, or a mixture.

Follow pain relief and side effects together

Log the medication's purpose alongside its dose. A treatment that substantially reduces pain or prevents seizures has a different benefit-risk balance from one that provides little relief while causing troublesome symptoms.

  • Track function. Note whether pain relief lets you walk farther or whether sleepiness reduces movement.
  • Record swelling. Include ankle swelling, tighter shoes, and whether symptoms change through the day.
  • Keep dosing accurate. Follow the prescribed schedule and record changes made by the clinician.

For someone with epilepsy, asking about alternatives requires reviewing seizure type, prior response, and other safety considerations. For someone with neuropathic pain, the discussion may focus more on symptom relief, sedation, and function.

Don't abruptly stop antiseizure treatment. Even when a medicine is being used for pain rather than epilepsy, ask the prescriber how to adjust it safely. A weight concern is a reason to review treatment, not to improvise a taper.

7. Non-Selective and Certain Beta-Blockers

Fatigue may be more informative than hunger when weight changes follow a beta-blocker prescription. Medicines such as propranolol, atenolol, metoprolol, and nadolol can reduce exercise tolerance or make usual activities feel harder. Some people then move less without consciously changing their routine.

Beta-blockers are used for different reasons, including heart conditions, blood pressure, migraine, and certain anxiety symptoms. Their weight effects aren't uniform, and a medicine's importance depends heavily on why it was prescribed. Evidence for weight effects with some antihypertensives is less certain than broad medication lists suggest.

A U.S. analysis of potentially weight-promoting prescriptions found that 9.8% of adults used beta-blockers in 2017–2018. That measures exposure to the drug class, not the percentage who gained weight.

Compare activity before and after treatment

Say someone starts atenolol and stops their evening walk because they feel unusually tired. A log showing reduced walking alongside fatigue is more useful than assuming the medicine directly increased body fat.

Record weight, activity, symptoms, and clinician-requested blood pressure or pulse measurements. Don't chase an old exercise heart-rate target without advice, because beta-blockers change the heart-rate response to exertion.

Ask whether fatigue is expected, whether another cause needs investigation, and whether the particular beta-blocker remains the best fit. Alternatives aren't interchangeable across heart failure, arrhythmias, migraine, and other indications.

Don't stop a beta-blocker abruptly. If you take it for heart failure, new swelling, breathlessness, or rapid weight change also needs assessment rather than being attributed automatically to a routine medication side effect.

8. Hormonal Therapies (Androgen Deprivation Therapy and Progestin-Based Contraceptives)

Body composition can change without a dramatic change on the scale. Androgen deprivation therapy, or ADT, used for prostate cancer can increase fat mass while reducing muscle mass. Medicines such as leuprolide and goserelin therefore call for attention to strength and function as well as weight.

Progestin-based contraception requires a separate discussion. Depot medroxyprogesterone acetate, or DMPA, has been associated with weight gain in some users, but responses vary and evidence isn't uniform across populations. Don't generalize one person's experience with an injectable contraceptive to every hormonal method.

Match the log to the treatment

For someone receiving ADT, useful records include resistance-training sessions, usual walking, appetite, waist measurements, and changes in everyday strength. Difficulty rising from a chair or carrying groceries may deserve discussion even if body weight looks stable.

For someone using DMPA, record injection dates, weight trends, appetite, and changes in activity or sleep. A sustained pattern across treatment is more informative than a single reading after an unusually salty meal.

  • During ADT. Ask the oncology team about suitable resistance exercise, nutrition support, and metabolic monitoring.
  • During contraceptive treatment. Discuss weight concerns alongside bleeding patterns, convenience, effectiveness needs, and other side effects.
  • For either treatment. Keep follow-up and injection appointments on the prescribed schedule rather than delaying them to test a weight theory.
A stable scale doesn't necessarily mean stable muscle mass, and a rising scale doesn't prove a hormonal treatment is the sole cause.

For example, a person receiving ADT might maintain weight while becoming weaker and less active. That deserves a different plan from someone whose main change is increased appetite. The clinician needs the treatment history and functional details to distinguish those situations.

How the Eight Medication Classes Compare on Weight-Gain Risk and Monitoring

ItemTypical Weight-Gain RiskMain MechanismKey Monitoring Step
Second-Generation (Atypical) AntipsychoticsOften substantial; varies by agentAppetite increase and altered glucose and lipid metabolismTrack weight, waist circumference, glucose, and lipids
Systemic CorticosteroidsDose- and duration-dependent; often greater with prolonged useIncreased appetite, fluid retention, and central fat redistributionTrack weight and sodium intake; monitor glucose during long courses
Certain Antidepressants (Mirtazapine, Tricyclics, and Paroxetine)Elevated for these agents; varies by medicationAppetite increase from histamine blockade and related effectsTrack weight and discuss changes with the prescriber
Insulin and SulfonylureasCommon; may occur early in treatmentIncreased insulin availability promotes fat storage; low blood sugar can prompt extra eatingLog glucose, meals, insulin doses, and HbA1c
Thiazolidinediones (Pioglitazone and Rosiglitazone)Common; can be significantFluid retention and increased subcutaneous fat storageTrack daily weight and report swelling or shortness of breath
Anticonvulsants with Weight-Gain Potential (Valproate, Gabapentin, and Pregabalin)Varies; can be substantial with valproateIncreased appetite, insulin resistance, or peripheral edemaTrack weight and swelling; share trends with the prescriber
Non-Selective and Certain Beta-BlockersUsually modestReduced metabolic rate and activity related to fatigueTrack weight and resting heart rate
Hormonal Therapies (Androgen Deprivation Therapy and Progestin-Based Contraceptives)Gradual; evidence varies, especially for DMPAIncreased fat mass, reduced muscle mass, and possible insulin resistanceTrack weight, waist circumference, and strength trends

Turn Weight Concerns into a Clinician Conversation

Medication-related weight gain isn't a single problem with a single solution. The right response depends on the medicine, dose, duration, treatment benefit, and whether the change reflects appetite, fluid, reduced activity, or recovery from illness. A useful plan protects the condition being treated while addressing the weight concern directly.

Bring a concise timeline rather than a collection of disconnected screenshots. Include the medication's name and indication, start date, prescribed dose changes, weight trend, and symptoms that appeared around the same time. Add glucose readings or laboratory results when they're relevant and available.

Ask for a plan that preserves treatment benefit

The conversation doesn't have to end with switching medicines. When a medication is essential, the clinician may consider nutrition and activity support, closer metabolic monitoring, or an additional treatment.

For antipsychotic-associated weight gain, a network meta-analysis of interventions found that metformin and liraglutide had the strongest evidence among the studied treatments. That's a discussion point for the prescriber, not a recommendation to obtain either medicine independently; suitability depends on the individual's health, existing treatment, and access.

Useful questions include:

  • What best explains this pattern? Ask whether fluid retention, appetite, illness recovery, or another medical condition needs assessment.
  • What should we monitor? Agree on relevant symptoms, measurements, laboratory tests, and follow-up.
  • What would prompt an earlier call? Request individualized instructions for rapid changes, swelling, or worsening symptoms.
  • What can change safely? Discuss the trade-offs of timing adjustments, alternatives, or additional treatment without sacrificing disease control.

At Stride, we bring meals, activity, weight, medications, and laboratory entries into one timeline so those details can be reviewed together. Our automated nutrition and activity estimates aren't clinical measurements, and our reminders aren't guaranteed to arrive; keep a dependable backup for essential medication schedules.

An app can support consistency, but it can't diagnose the cause of weight gain or decide whether a prescription should change. If weighing becomes distressing, ask your clinician for a monitoring approach that provides useful information without increasing anxiety.

Start recording now, and bring the pattern to your next appointment. Contact your care team sooner for rapid unexplained changes or new swelling, and seek urgent assessment for severe breathing difficulty or chest discomfort. Don't wait for a perfect log before asking for help.


Stride offers a shared place to record medications, meals, movement, weight, and laboratory results so you can compare changes over time. Visit Stride to build a daily tracking routine and prepare a clearer medication-and-weight history for your prescriber.

Put this into practice with Stride

Log meals, training, weight and sleep in seconds, then get guidance that fits your own numbers.

Try Stride free
All articles